:::°æÈñ´ëÇб³ ÇÑÀÇ°ú´ëÇÐ ¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬¼ö¼¾ÅÍ¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù:::
:::°æÈñ´ëÇб³ ÇÑÀÇ°ú´ëÇÐ ¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬¼ö¼¾ÅÍ¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù:::
¡¡
¡¡
   
  2007 CPMDRC Workshop
  ±Û¾´ÀÌ : ÃÖ°í°ü¸®ÀÚ     ³¯Â¥ : 07-12-05 13:51     Á¶È¸ : 1773    
2007³â CPMDRC Workshop °øÁö

1. ÀϽà : 2007³â 12¿ù 13~14ÀÏ

2. Àå¼Ò : °æ±âµµ ¾çÆò ÇÑÈ­Äܵµ

3. ÀÏÁ¤ : ÀÚ¼¼ÇÑ ÀÏÁ¤ ÃßÈÄ °³º° °øÁö

4. ¹ßÇ¥

* Ç÷°üÇü¼º ½ÇÇè±â¹ý(ÀÌÀº¿Á)

* Çѹæ¼ÒÀçÀÇ Ç÷°üÇü¼ºÀúÇØÈ°¼º(ÀÌÈ¿Á¤)

* Regulation of cisplatin-induced cytotoxicity on auditory cells.(Á¤ÇöÀÚ)

* The protective mechanism of antioxidant in cadmium-induced ototoxicity in vitro and in vivo(±è¼öÁø)

* MOUTAN CORTEX inhibits the CD4+CD25+ regulatory T cell pool and tumor trafficking(ÀÌÈñ°æ)

* Á¶Àý T ¼¼Æ÷¿¡¼­ human telomerase reverse transcriptase (hTERT)¹ßÇöÀ» ÅëÇÑ hTERT-immortalized cell line Á¦ÀÛ(Á¤È¯¼®)

* Research for the effect of Regulatory T-Cell on Cisplatin induced Nephrotoxicity(ÀÌÈ¿Á¤)


¸¹Àº Âü¼® ºÎŹµå¸³´Ï´Ù.

   

:::°æÈñ´ëÇб³ ÇÑÀÇ°ú´ëÇÐ ¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬¼ö¼¾ÅÍ¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù:::